Industry: Medical Devices & Consumables
Published Date: 2024-11-15
Pages: 93 Pages
Report ld: 3376908
Request Sample
Customized Report
Stereotactic Radiation Therapy (SRT) System Market Size(US$)

CAGR 2024-2030
23.2%
Market Size,2030
USD 1,034
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 259 million in 2023 and is forecast to a readjusted size of US$ 1034 million by 2030 with a CAGR of 23.2% during the forecast period 2024-2030.
Improvements in tumor localization, imaging and dosimetry in radiotherapy has allowed for the implementation of hypofractionated radiotherapy for disease sites where conventional fractionation (around 2 Gy per fraction) was previously the norm or where curative radiotherapy was not attempted. SRT comprises high-precision irradiation techniques that use multiple, photon radiation beams to deliver a high dose of radiation. Stereotactic localization, using frame-based or frameless techniques, is used to treat lesions. Regarding dose fractionation, SRT is divided into stereotactic radiosurgery (SRS), in which the total dose is delivered in a single treatment session, and stereotactic radiotherapy, in which the total dose is delivered in multiple fractions (usually less than 8 treatments). Originally this technique was only used when treating lesions located in the brain, however now a number of extra-cranial malignancies are treated using stereotactic localization (stereotactic body radiotherapy (SBRT)).
North American market for Stereotactic Radiation Therapy (SRT) System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Stereotactic Radiation Therapy (SRT) System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Stereotactic Radiation Therapy (SRT) System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Stereotactic Radiation Therapy (SRT) System include Elekta, Accuray Incorporated, MASEP Medical Science & Technology Development (Shenzhen), China Isotope & Radiation Corporation, Huiheng Group, OUR United Gorp, Jiangsu Rayer Medical Technology, Hygeia Healthcare Holdings, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Stereotactic Radiation Therapy (SRT) System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Stereotactic Radiation Therapy (SRT) System by region & country, by Type, and by Application.
The Stereotactic Radiation Therapy (SRT) System market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stereotactic Radiation Therapy (SRT) System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Stereotactic Radiation Therapy (SRT) System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Stereotactic Radiation Therapy (SRT) System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Stereotactic Radiation Therapy (SRT) System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Stereotactic Radiation Therapy (SRT) System Product Introduction
1.2 Global Stereotactic Radiation Therapy (SRT) System Market Size Forecast
1.2.1 Global Stereotactic Radiation Therapy (SRT) System Sales Value (2019-2030)
1.2.2 Global Stereotactic Radiation Therapy (SRT) System Sales Volume (2019-2030)
1.2.3 Global Stereotactic Radiation Therapy (SRT) System Sales Price (2019-2030)
1.3 Stereotactic Radiation Therapy (SRT) System Market Trends & Drivers
1.3.1 Stereotactic Radiation Therapy (SRT) System Industry Trends
1.3.2 Stereotactic Radiation Therapy (SRT) System Market Drivers & Opportunity
1.3.3 Stereotactic Radiation Therapy (SRT) System Market Challenges
1.3.4 Stereotactic Radiation Therapy (SRT) System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Stereotactic Radiation Therapy (SRT) System Players Revenue Ranking (2023)
2.2 Global Stereotactic Radiation Therapy (SRT) System Revenue by Company (2019-2024)
2.3 Global Stereotactic Radiation Therapy (SRT) System Players Sales Volume Ranking (2023)
2.4 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Company Players (2019-2024)
2.5 Global Stereotactic Radiation Therapy (SRT) System Average Price by Company (2019-2024)
2.6 Key Manufacturers Stereotactic Radiation Therapy (SRT) System Manufacturing Base and Headquarters
2.7 Key Manufacturers Stereotactic Radiation Therapy (SRT) System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Stereotactic Radiation Therapy (SRT) System
2.9 Stereotactic Radiation Therapy (SRT) System Market Competitive Analysis
2.9.1 Stereotactic Radiation Therapy (SRT) System Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Stereotactic Radiation Therapy (SRT) System Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stereotactic Radiation Therapy (SRT) System as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 X-rays
3.1.2 Gamma-rays
3.2 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Type
3.2.1 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Stereotactic Radiation Therapy (SRT) System Sales Value, by Type (2019-2030)
3.2.3 Global Stereotactic Radiation Therapy (SRT) System Sales Value, by Type (%) (2019-2030)
3.3 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Type
3.3.1 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Stereotactic Radiation Therapy (SRT) System Sales Volume, by Type (2019-2030)
3.3.3 Global Stereotactic Radiation Therapy (SRT) System Sales Volume, by Type (%) (2019-2030)
3.4 Global Stereotactic Radiation Therapy (SRT) System Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Application
4.2.1 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Stereotactic Radiation Therapy (SRT) System Sales Value, by Application (2019-2030)
4.2.3 Global Stereotactic Radiation Therapy (SRT) System Sales Value, by Application (%) (2019-2030)
4.3 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Application
4.3.1 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Stereotactic Radiation Therapy (SRT) System Sales Volume, by Application (2019-2030)
4.3.3 Global Stereotactic Radiation Therapy (SRT) System Sales Volume, by Application (%) (2019-2030)
4.4 Global Stereotactic Radiation Therapy (SRT) System Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Region
5.1.1 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Region (2019-2024)
5.1.3 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Region (2025-2030)
5.1.4 Global Stereotactic Radiation Therapy (SRT) System Sales Value by Region (%), (2019-2030)
5.2 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Region
5.2.1 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Region (2019-2024)
5.2.3 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Region (2025-2030)
5.2.4 Global Stereotactic Radiation Therapy (SRT) System Sales Volume by Region (%), (2019-2030)
5.3 Global Stereotactic Radiation Therapy (SRT) System Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
5.4.2 North America Stereotactic Radiation Therapy (SRT) System Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
5.5.2 Europe Stereotactic Radiation Therapy (SRT) System Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
5.6.2 Asia Pacific Stereotactic Radiation Therapy (SRT) System Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
5.7.2 South America Stereotactic Radiation Therapy (SRT) System Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
5.8.2 Middle East & Africa Stereotactic Radiation Therapy (SRT) System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Stereotactic Radiation Therapy (SRT) System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Stereotactic Radiation Therapy (SRT) System Sales Value
6.2.1 Key Countries/Regions Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.2.2 Key Countries/Regions Stereotactic Radiation Therapy (SRT) System Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.3.2 United States Stereotactic Radiation Therapy (SRT) System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Stereotactic Radiation Therapy (SRT) System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.4.2 Europe Stereotactic Radiation Therapy (SRT) System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Stereotactic Radiation Therapy (SRT) System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.5.2 China Stereotactic Radiation Therapy (SRT) System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Stereotactic Radiation Therapy (SRT) System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.6.2 Japan Stereotactic Radiation Therapy (SRT) System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Stereotactic Radiation Therapy (SRT) System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.7.2 South Korea Stereotactic Radiation Therapy (SRT) System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Stereotactic Radiation Therapy (SRT) System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.8.2 Southeast Asia Stereotactic Radiation Therapy (SRT) System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Stereotactic Radiation Therapy (SRT) System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Stereotactic Radiation Therapy (SRT) System Sales Value, 2019-2030
6.9.2 India Stereotactic Radiation Therapy (SRT) System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Stereotactic Radiation Therapy (SRT) System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Elekta
7.1.1 Elekta Company Information
7.1.2 Elekta Introduction and Business Overview
7.1.3 Elekta Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Elekta Stereotactic Radiation Therapy (SRT) System Product Offerings
7.1.5 Elekta Recent Development
7.2 Accuray Incorporated
7.2.1 Accuray Incorporated Company Information
7.2.2 Accuray Incorporated Introduction and Business Overview
7.2.3 Accuray Incorporated Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Accuray Incorporated Stereotactic Radiation Therapy (SRT) System Product Offerings
7.2.5 Accuray Incorporated Recent Development
7.3 MASEP Medical Science & Technology Development (Shenzhen)
7.3.1 MASEP Medical Science & Technology Development (Shenzhen) Company Information
7.3.2 MASEP Medical Science & Technology Development (Shenzhen) Introduction and Business Overview
7.3.3 MASEP Medical Science & Technology Development (Shenzhen) Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 MASEP Medical Science & Technology Development (Shenzhen) Stereotactic Radiation Therapy (SRT) System Product Offerings
7.3.5 MASEP Medical Science & Technology Development (Shenzhen) Recent Development
7.4 China Isotope & Radiation Corporation
7.4.1 China Isotope & Radiation Corporation Company Information
7.4.2 China Isotope & Radiation Corporation Introduction and Business Overview
7.4.3 China Isotope & Radiation Corporation Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 China Isotope & Radiation Corporation Stereotactic Radiation Therapy (SRT) System Product Offerings
7.4.5 China Isotope & Radiation Corporation Recent Development
7.5 Huiheng Group
7.5.1 Huiheng Group Company Information
7.5.2 Huiheng Group Introduction and Business Overview
7.5.3 Huiheng Group Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Huiheng Group Stereotactic Radiation Therapy (SRT) System Product Offerings
7.5.5 Huiheng Group Recent Development
7.6 OUR United Gorp
7.6.1 OUR United Gorp Company Information
7.6.2 OUR United Gorp Introduction and Business Overview
7.6.3 OUR United Gorp Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 OUR United Gorp Stereotactic Radiation Therapy (SRT) System Product Offerings
7.6.5 OUR United Gorp Recent Development
7.7 Jiangsu Rayer Medical Technology
7.7.1 Jiangsu Rayer Medical Technology Company Information
7.7.2 Jiangsu Rayer Medical Technology Introduction and Business Overview
7.7.3 Jiangsu Rayer Medical Technology Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Jiangsu Rayer Medical Technology Stereotactic Radiation Therapy (SRT) System Product Offerings
7.7.5 Jiangsu Rayer Medical Technology Recent Development
7.8 Hygeia Healthcare Holdings
7.8.1 Hygeia Healthcare Holdings Company Information
7.8.2 Hygeia Healthcare Holdings Introduction and Business Overview
7.8.3 Hygeia Healthcare Holdings Stereotactic Radiation Therapy (SRT) System Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Hygeia Healthcare Holdings Stereotactic Radiation Therapy (SRT) System Product Offerings
7.8.5 Hygeia Healthcare Holdings Recent Development
8 Industry Chain Analysis
8.1 Stereotactic Radiation Therapy (SRT) System Industrial Chain
8.2 Stereotactic Radiation Therapy (SRT) System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Stereotactic Radiation Therapy (SRT) System Sales Model
8.5.2 Sales Channel
8.5.3 Stereotactic Radiation Therapy (SRT) System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 357 million in 2025 to US$ 1510 million by 2032, at a CAGR of 23.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 133
USD 4900.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 357 million in 2025 and is forecast to reach a readjusted size of US$ 1510 million by 2032 with a CAGR of 23.2% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 80
USD 4250.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market was valued at US$ 357 million in 2025 and is anticipated to reach US$ 1510 million by 2032, at a CAGR of 23.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 115
USD 2900.00
(Single User License)
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 357 million in 2025 and is projected to reach US$ 1510 million, growing at a CAGR of 23.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 100
USD 3950.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1249 million by 2031, at a CAGR of 23.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 150
USD 4900.00
(Single User License)
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 107
USD 3950.00
(Single User License)
The global market for Stereotactic Radiation Therapy (SRT) System was valued at US$ 296 million in the year 2024 and is projected to reach a revised size of US$ 1249 million by 2031, growing at a CAGR of 23.2% during the forecast period.
Published Date: 2025-03-10
Pages: 79
USD 2900.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1034 million by 2030, at a Compound Annual Growth Rate (CAGR) of 23.2% during the forecast period.
Published Date: 2024-11-15
Pages: 133
USD 4900.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System revenue was US$ 259 million in 2023 and is forecast to a readjusted size of US$ 1034 million by 2030 with a CAGR of 23.2% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 116
USD 4350.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 357 million in 2025 to US$ 1510 million by 2032, at a CAGR of 23.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 133
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 357 million in 2025 and is forecast to reach a readjusted size of US$ 1510 million by 2032 with a CAGR of 23.2% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 80
The global Stereotactic Radiation Therapy (SRT) System market was valued at US$ 357 million in 2025 and is anticipated to reach US$ 1510 million by 2032, at a CAGR of 23.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 115
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 357 million in 2025 and is projected to reach US$ 1510 million, growing at a CAGR of 23.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 100
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1249 million by 2031, at a CAGR of 23.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 150
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 107
The global market for Stereotactic Radiation Therapy (SRT) System was valued at US$ 296 million in the year 2024 and is projected to reach a revised size of US$ 1249 million by 2031, growing at a CAGR of 23.2% during the forecast period.
Published: 2025-03-10
Pages: 79
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1034 million by 2030, at a Compound Annual Growth Rate (CAGR) of 23.2% during the forecast period.
Published: 2024-11-15
Pages: 133
The global Stereotactic Radiation Therapy (SRT) System revenue was US$ 259 million in 2023 and is forecast to a readjusted size of US$ 1034 million by 2030 with a CAGR of 23.2% during the review period (2024-2030).
Published: 2024-11-15
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now